Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03313895 · ClinicalTrials.gov registry record · NA

The Combined Aerobic Exercise and Cognitive Training (ACT) Trial: The ACT Trial

A NA study, sponsored by Arizona State University.

Completed
Registry status
NA
Development phase
146
Enrollment target

NCT03313895: Completed NA study, sponsored by Arizona State University.

NCT03313895 is a NA study that has completed, run by Arizona State University. The registered enrollment target is 146 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03313895, a NA study, has completed, sponsored by Arizona State University.

COMPLETED
Registry status
NA
Development phase
146 participants
Enrollment target

Study Summary

This multi-site clinical trial occurs at the University of Minnesota and University of Rochester. It tests the efficacy and additive/synergistic effects of an ACT intervention on cognition and relevant mechanisms (aerobic fitness, Alzheimer's disease \[AD\] signature cortical thickness, and default mode network \[DMN\]) in older adults with amnestic MCI (aMCI).

Primary Outcome

EXAMINER

Interventions

  • BEHAVIORAL Aerobic & Cognitive Training (ACT)
  • BEHAVIORAL Cycling Only
  • BEHAVIORAL Cognitive Training Only
  • BEHAVIORAL Stretching and Mental Stimulating Activities

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2018-07-05
Est. Completion 2024-07-17
Phase NA
Arizona State University

187 total trials

What the finished NCT03313895 record still lists

NCT03313895 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 4 interventions - of which Aerobic & Cognitive Training (ACT) is the first listed.

NCT03313895 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03313895 about?

NCT03313895 is a clinical study titled "The Combined Aerobic Exercise and Cognitive Training (ACT) Trial: The ACT Trial". This multi-site clinical trial occurs at the University of Minnesota and University of Rochester. It tests the efficacy and additive/synergistic effects of an ACT intervention on cognition and relevant mechanisms (aerobic fitness, Alzheimer's disease \[AD\] signature cortical thickness, and default ...

What is the current status of trial NCT03313895?

This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2018-07-05. Estimated completion is 2024-07-17.

What interventions are being tested in trial NCT03313895?

The interventions under investigation include: Aerobic & Cognitive Training (ACT) (BEHAVIORAL), Cycling Only (BEHAVIORAL), Cognitive Training Only (BEHAVIORAL), Stretching and Mental Stimulating Activities (BEHAVIORAL).

Who is sponsoring clinical trial NCT03313895?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03313895's enrollment target sits among peer trials

146 704th of 2000 higher than 1,296 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03490929 · 146 participants · Phase 4

    CEUS for Blunt Abdominal Trauma in Children

  • NCT04755062 · 146 participants · NA

    A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans

  • NCT04867954 · 146 participants

    Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis

  • NCT05051618 · 146 participants · NA

    Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03313895, the US trial registry maintained by the National Library of Medicine. NCT03313895 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.